Journal scan

Blood plasma test could lead to earlier diagnosis of autism

A pioneering test has revealed a link between autism and damage to proteins in blood plasma that could lead to earlier diagnosis of the condition, scientists say

A pioneering test has revealed a link between autism and damage to proteins in blood plasma that could lead to earlier diagnosis of the condition, scientists say.

An international team including researchers from the University of Warwick and the University of Bologna in Italy developed urine and blood tests to detect signs of autism spectrum conditions (ASC) in children.

A total of 38 children from Bologna with ASC were studied alongside a control group of 31 children who did not have ASC.

Blood and urine samples were taken and analysed using artificial intelligence algorithms to develop a mathematical equation that could distinguish between ASC and the controls.

Genetic causes

The team found links between oxidation and glycation processes where oxygen particles and sugar molecules spontaneously modify proteins and ASC.

Genetic causes have been found in 3035%

...

Picture: iStock

A pioneering test has revealed a link between autism and damage to proteins in blood plasma that could lead to earlier diagnosis of the condition, scientists say.

An international team including researchers from the University of Warwick and the University of Bologna in Italy developed urine and blood tests to detect signs of autism spectrum conditions (ASC) in children.

A total of 38 children from Bologna with ASC were studied alongside a control group of 31 children who did not have ASC.

Blood and urine samples were taken and analysed using artificial intelligence algorithms to develop a mathematical equation that could distinguish between ASC and the controls.

Genetic causes

The team found links between oxidation and glycation – processes where oxygen particles and sugar molecules spontaneously modify proteins – and ASC.

Genetic causes have been found in 30–35% of cases of ASC and the remaining 65–70% of cases are thought to be caused by a combination of environmental factors, multiple mutations and rare genetic variants.

Lead author and University of Warwick reader of experimental systems biology Naila Rabbani said: ‘With further testing we may reveal specific plasma and urinary profiles or “fingerprints” of compounds with damaging modifications.’

This could help improve the diagnosis of ASC and point to new causes of it, the researcher said.


Rabbani N et al (2018) Advanced glycation endproducts, dityrosine, and arginine transporter dysfunction in autism – a source of biomarkers for clinical diagnosis. Molecular Autism. doi:10.1186/s13229-017-0183-3

Further information

Read the study

Want to read more?

Subscribe for unlimited access

Enjoy 1 month's access for £1 and get:

  • Full access to learningdisabilitypractice.com
  • Bi-monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal

This article is not available as part of an institutional subscription. Why is this?

Jobs